Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000907628 | SCV001052344 | likely benign | Polyglandular autoimmune syndrome, type 1 | 2024-01-22 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV000907628 | SCV001460106 | likely benign | Polyglandular autoimmune syndrome, type 1 | 2020-06-05 | no assertion criteria provided | clinical testing | |
Genome Diagnostics Laboratory, |
RCV001702570 | SCV001931716 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001702570 | SCV001966970 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV004754622 | SCV005353604 | likely benign | AIRE-related disorder | 2024-08-14 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |